Hos patienter, som ikke opretholder et vedvarende serologisk respons, bør behandling med enten lamivudin eller et andet antiviralt lægemiddel overvejes for at genoprette klinisk kontrol af HBV.
In patients who do not maintain a sustained serological response, consideration should be given to retreatment with either lamivudine or an alternative antiviral agent for resumption of clinical control of HBV.